# The Efficacy of Citalopram Treatment in Acute Stroke

Study · id `cardio:ct-nct01937182` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01937182](<https://clinicaltrials.gov/study/NCT01937182>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01937182

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 642 participants.

## Technical summary

Registry record NCT01937182. Randomized; quadruple masking; primary purpose treatment. Start 2013-09 (actual); primary completion 2016-12-19 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 642 participants (enrolled count; ClinicalTrials.gov record NCT01937182, source copy `cardio:ctgov-nct01937182-2017-02-24`, retrieved 2026-10-26)
- Started: 2013-09 (actual) (ClinicalTrials.gov record NCT01937182, source copy `cardio:ctgov-nct01937182-2017-02-24`, retrieved 2026-10-26)
- Primary completion: 2016-12-19 (actual) (ClinicalTrials.gov record NCT01937182, source copy `cardio:ctgov-nct01937182-2017-02-24`, retrieved 2026-10-26)
- Completion: 2016-12-19 (actual) (ClinicalTrials.gov record NCT01937182, source copy `cardio:ctgov-nct01937182-2017-02-24`, retrieved 2026-10-26)
- Countries: Denmark (ClinicalTrials.gov record NCT01937182, source copy `cardio:ctgov-nct01937182-2017-02-24`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01937182-2017-02-24`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Efficacy of Citalopram Treatment in Acute Stroke
- Acronym: TALOS
- Condition: Stroke, Ischemic
- Intervention (Drug): Citalopram
- Intervention (Drug): Placebo
- Lead sponsor: University of Aarhus
- Lead sponsor class: OTHER
- Collaborator: Danish Council for Independent Research
- Collaborator class: OTHER
- Collaborator: The Danish Regions Medicine Foundation
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: University of Aarhus (`cardio:org-university-of-aarhus`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Neuroregeneration and Vascular Protection by Citalopram in Acute Ischemic Stroke (TALOS) (`cardio:pubmed-30355209`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Impact of prestroke physical activity and citalopram treatment on poststroke depressive symptoms: a secondary analysis of data from the TALOS randomised controlled trial in Denmark (`cardio:pubmed-36997260`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 1ac8e829c6e562349f66dceaf83bcea880ca632d399ffb188b399d333330f549
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
